Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exicilia serum for eyebrow hypotrichosis
IRCT20150101020514N9Phase 2Completed
- Sponsor
- CinnaGen
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bimatoprost in Eyebrow hypotrichosis, sponsored by CinnaGen. Primary endpoint: Percentage of people with one grade or more improvement in GEBA scale. Started Aug 2020; status: completed.
02
Drugs
bimatoprost
03
Conditions
Eyebrow hypotrichosis
Beyond the preview
Go deeper on IRCT20150101020514N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150101020514N9.